Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04114903 · ClinicalTrials.gov registry record
Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity
A clinical trial, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- 255
- Enrollment target
NCT04114903: Completed study, sponsored by University of Colorado, Boulder.
NCT04114903 is a clinical trial that has completed, run by University of Colorado, Boulder. The registered enrollment target is 255 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04114903 has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
This study tests the effects of cannabinoid levels in blood on inflammation and insulin sensitivity both acutely and chronically in individuals across the weight spectrum. To that end, the study employs two observational designs: 1) A study of acute effects with intermittent cannabis users and 2) A study in which current cannabis users will select one of three cannabis strains for four weeks and are compared to a matched control group who do not use cannabis to study chronic effects. Blood levels of THC and CBD, inflammatory biomarkers, and insulin resistance will be measured in both studies.
Primary Outcome
Change in Circulating Levels of Cytokines (TNF-α, IL-6, IL-1β, IL-12, IFNG, and IL-4). Results are reported as a composite score of TNF-α, IL-6, IL-1β, IL-12, IFNG, and IL-4
Interventions
- OTHER Study A: Single use of cannabis flower product
- OTHER Study B: Ad libitum cannabis use for four weeks or no cannabis use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2019-11-08 |
| Est. Completion | 2024-12-01 |
What the finished NCT04114903 record still lists
NCT04114903 is an observational study that tracks outcomes without assigning an intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Study A: Single use of cannabis flower product is the first listed.
NCT04114903 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04114903 about?
NCT04114903 is a clinical study titled "Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity". This study tests the effects of cannabinoid levels in blood on inflammation and insulin sensitivity both acutely and chronically in individuals across the weight spectrum. To that end, the study employs two observational designs: 1) A study of acute effects with intermittent cannabis users and 2) A ...
What is the current status of trial NCT04114903?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2019-11-08. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT04114903?
The interventions under investigation include: Study A: Single use of cannabis flower product (OTHER), Study B: Ad libitum cannabis use for four weeks or no cannabis use (OTHER).
Who is sponsoring clinical trial NCT04114903?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI